ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Sanofi

Sanofi (SNW)

76,73
2,08
(2,79%)
Geschlossen 10 Juli 10:00PM

Sanofi (SNW) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
76,73
( 2,79% )
Gebot
76,66
Fragen
76,80
Volumen
9.158
Durchschnittliches Volumen (3 Mio.)
2.491.718 €
Finanzvolumen
-
74,61 Tagesbereich 77,10
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Unternehmenswert
105,801B
Handelsende
74,65
Handelsbeginn
74,86
Letzte Trade
31
@
76.58
Letzter Handelszeitpunkt
VWAP
-
Erlöse (LTM)
47,35B
Nettogewinn (LTM)
7,56B
Ausgegebene Aktien
1.200.220.109
Streubesitz (%)
90,30%
Institutioneller Besitz (%)
44,40%
Dividendenrendite (LTM)
(5,35%)
Kurs-Gewinn-Verhältnis
19,12
Kurs-Umsatz-Verhältnis (KUV)
1,92
Gewinn pro Aktie (EPS)
6,2
Beta
0,28

Über Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respi... Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine’s AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV’574, for treatment of ulcerative colitis and Crohn’s disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Website
Hauptsitz
Paris, France
Gegründet
1994
Sanofi is listed in the Healthcare sector of the Tradegate (DE) with ticker SNW. The last closing price for Sanofi was 74,65 €. Over the last year, Sanofi shares have traded in a share price range of 0,00 € to 0,00 €.

Sanofi currently has 1.200.220.109 shares in issue. The market capitalisation of Sanofi is 92,09 € billion. Sanofi has a price to earnings ratio (PE ratio) of 19.12.

SNW Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

SNW - Frequently Asked Questions (FAQ)

What is the current Sanofi share price?
The current share price of Sanofi is 76,73 €
How many Sanofi shares are in issue?
Sanofi has 1.200.220.109 shares in issue
What is the market cap of Sanofi?
The market capitalisation of Sanofi is EUR 92,09B
What is the 1 year trading range for Sanofi share price?
Sanofi has traded in the range of 0,00 € to 0,00 € during the past year
What is the PE ratio of Sanofi?
The price to earnings ratio of Sanofi is 19,12
What is the cash to sales ratio of Sanofi?
The cash to sales ratio of Sanofi is 1,92
What is the registered address of Sanofi?
The registered address for Sanofi is 46, avenue de la Grande ArmEe, Paris, Ile-de-France, 75017
What is the Sanofi website address?
The website address for Sanofi is www.sanofi.com
Which industry sector does Sanofi operate in?
Sanofi operates in the Pharmaceuticals sector

SNW Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen